Dainippon Sumitomo Pharma opens subsidiary in Singapore

TOKYO —

Dainippon Sumitomo Pharma (DSP) has set up a wholly owned subsidiary, Sunovion Pharmaceuticals Asia Pacific Pte Ltd, in Singapore as a base of operations in Southeast Asia.

DSP said it is progressing its global expansion with its global strategic product, antipsychotic lurasidone hydrochloride (generic name) at the core. As a part of this effort, DSP has considered extending commercial operations for lurasidone hydrochloride to countries in Southeast Asia where growth is expected in the mid-to long term.

DSP said it will first promote business operations such as obtaining approval for and marketing lurasidone hydrochloride in Southeast Asia through partnerships with local companies. Using Singapore as a base of operations, DSP will consider successive expansion of its product lineups in Southeast Asia and additionally business expansion into neighboring countries such as Australia.

JCN Newswire

Login to leave a comment

OR
  • Reservations and Operations Executive

    Reservations and Operations Executive
    Destination Asia Japan、Tokyo
    Salary: ¥2.0M ~ ¥3.0M / Year
  • Marketing & Communications

    Marketing & Communications
    East West Consulting (イーストウエストコンサルティング株式会社)、Tokyo
    Salary: Salary negotiable
  • Country Manager

    Country Manager
    Gallo Japan KK、Tokyo
    Salary: Salary negotiable
  • Business Development Leader

    Business Development Leader
    GPlus Media K.K. / 株式会社ジープラス・メディア、Tokyo
    Salary: Salary negotiable Commission Based Depending on Experience
  • IT Operations Manager

    IT Operations Manager
    Temple University, Japan Campus - テンプル大学ジャパンキャンパス、Tokyo
    Salary: Commensurate with experience plus transportation from/to TUJ

More in Business

View all

View all